Author Question: The client receives zafirlukast (Accolate) as treatment for asthma. The nurse has completed ... (Read 55 times)

cherise1989 · **on:** Jul 23, 2018

The client receives zafirlukast (Accolate) as treatment for asthma. The nurse has completed medication education and evaluates that learning has occurred when the client makes which statement?

1. This medication activates my fight-or-flight response.
2. This medication is good when I have an acute attack of asthma.
3. This medication dilates my airways so I can breathe better.
4. This medication decreases the inflammation in my lungs.

Question 2

The client receives isoproterenol (Isuprel) via inhalation. The nurse determines that the client is experiencing a side effect of this medication when reviewing which laboratory test?

1. AST of 20 units/L
2. Sodium of 160
3. Glucose of 145
4. Creatinine of 1.0 mg/dl

HandsomeMarc · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 4
Rationale 1: Zafirlukast (Accolate) does not stimulate the sympathetic nervous system.
Rationale 2: Zafirlukast (Accolate) is ineffective for acute asthma attacks.
Rationale 3: Zafirlukast (Accolate) is not a bronchodilator.
Rationale 4: Zafirlukast (Accolate) prevents airway edema and inflammation by blocking leukotriene receptors in the airways.

Answer to Question 2

Correct Answer: 3
Rationale: A side effect of isoproterenol (Isuprel) is hyperglycemia. A creatinine of 1.0 mg/dl is a normal creatinine level, and isoproterenol (Isuprel) is not nephrotoxic. A sodium of 160 is an elevated sodium level, but isoproterenol (Isuprel) does not cause hypernatremia. An AST of 20 units/L is a normal AST, and isoproterenol (Isuprel) is not hepatotoxic.